Search results for "Systemic."

showing 10 items of 756 documents

2013 ECONOMY MOMENTUM CHALLENGES FOR NEXT 10 YEARS

2013

Last 5 years of almost unprecedented financial market turmoil it s still generating comprehensive crisis theories, market paradigms and nevertheless unprecedented situations. The aim of this paper is to explain 2013 milestone momentum for new market rules and regulations implementation - Basel III. The expected immediate cushion factors as well the possible negative impact on financial markets is presented from financial institutions perspective. Finally, the paper seeks for an exploratory after 10 years scenario connected with imminent market evolution and tendencies.

Basel III systemic risk sovereign debt crisis risk capitalRevista Economica
researchProduct

Influence of a bioceramic root end material and mineral trioxide aggregates on fibroblasts and osteoblasts

2012

The biocompatibility of materials used in endodontic treatment is of high importance, because they can come in contact with periradicular tissues and there is a risk of possible systemic toxicity. The aim of the present study was to investigate the in vitro reaction to a bioceramic based root end material in comparison to mineral trioxide aggregates (MTA) as the established gold standard.The root end materials grey MTA Angelus (GMTA), white MTA Angelus (WMTA), ProRoot MTA, and EndoSequence Root Repair Material (ERRM) were incubated with human periodontal ligament fibroblasts and osteoblasts (10(4)cells/ml) for up to 96h. Cell proliferation (RFU) was determined by means of the Alamar Blue as…

BiocompatibilityPeriodontal LigamentCell Culture TechniquesDentistryBiocompatible MaterialsBioceramicRoot Canal Filling Materialschemistry.chemical_compoundHumansAluminum CompoundsGeneral DentistryCell ProliferationOsteoblastsbusiness.industrySilicatesOxidesCell BiologyGeneral MedicineCalcium CompoundsFibroblastsDrug CombinationsPeriradicularSystemic toxicityOtorhinolaryngologychemistryBiological AssaybusinessTrioxideArchives of Oral Biology
researchProduct

Density of conjugated antibody determines the extent of Fc receptor dependent capture of nanoparticles by liver sinusoidal endothelial cells

2021

Despite considerable progress in the design of multifunctionalized nanoparticles (NPs) that selectively target specific cell types, their systemic application often results in unwanted liver accumulation. The exact mechanisms for this general observation are still unclear. Here we asked whether the number of cell-targeting antibodies per NP determines the extent of NP liver accumulation and also addressed the mechanisms by which antibody-coated NPs are retained in the liver. We used polysarcosine-based peptobrushes (PBs), which in an unmodified form remain in the circulation for >24 h due to the absence of a protein corona formation and low unspecific cell binding, and conjugated them with …

Biodistributionbiologymedicine.diagnostic_testChemistryCellGeneral EngineeringFc receptorGeneral Physics and AstronomyEndothelial CellsDendritic cellReceptors FcFlow cytometryCell biologymedicine.anatomical_structureLiverbiology.proteinmedicineSystemic administrationNanoparticlesGeneral Materials ScienceTissue DistributionAntibodyReceptor
researchProduct

Minor changes in the macrocyclic ligands but major consequences on the efficiency of gold nanoparticles designed for radiosensitization

2016

International audience; Many studies have been devoted to adapting the design of gold nanoparticles to efficiently exploit their promising capability to enhance the effects of radiotherapy. In particular, the addition of magnetic resonance imaging modality constitutes an attractive strategy for enhancing the selectivity of radiotherapy since it allows the determination of the most suited delay between the injection of nanoparticles and irradiation. This requires the functionalization of the gold core by an organic shell composed of thiolated gadolinium chelates. The risk of nephrogenic systemic fibrosis induced by the release of gadolinium ions should encourage the use of macrocyclic chelat…

BiodistributiontumorMaterials scienceGadoliniumchemistry.chemical_elementNanoparticleContext (language use)Nanotechnology02 engineering and technology[CHIM.THER]Chemical Sciences/Medicinal Chemistry010402 general chemistry01 natural sciences[ CHIM ] Chemical Sciencesnephrogenic systemic fibrosis[CHIM]Chemical SciencesGeneral Materials ScienceChelationratbiodistributionradiotherapyrenal clearance[ CHIM.THER ] Chemical Sciences/Medicinal Chemistry021001 nanoscience & nanotechnologyCombinatorial chemistry0104 chemical scienceschemistrymri contrast agentsColloidal goldSurface modification0210 nano-technologySelectivitydihydrolipoic acidmicrobeam radiation-therapy9l gliosarcoma
researchProduct

Label-free piezoelectric biosensor for prognosis and diagnosis of Systemic Lupus Erythematosus

2017

[EN] An autoantigen piezoelectric sensor to quantify specific circulating autoantibodies in human serum is developed. The sensor consisted on a quartz crystal microbalance with dissipation monitoring (QCM-D) where TRIM21 and TROVE2 autoantigens were covalently immobilized, allowing the selective determination of autoantibodies for diagnosis and prognosis of Systemic Lupus Erythematosus (SLE). The sensitivity of the biosensor, measured as IC50 value, was 1.51 U/mL and 0.32 U/mL, for anti-TRIM21 and anti-TROVE2 circulating autoantibodies, respectively. The sensor is also able to establish a structural interaction fingerprint pattern or profile of circulating autoantibodies, what allows scorin…

Biomedical EngineeringBiophysicsEarly detectionBiosensing Techniques02 engineering and technologyImmunosensorDissipation monitoringAutoantigensSensitivity and SpecificitySystemic Lupus Erythematosus01 natural sciencesQuartz crystal microbalanceRNA Small CytoplasmicDiagnosisQUIMICA ANALITICAElectrochemistryHumansLupus Erythematosus SystemicMedicineMultiplexPiezoelectric biosensorAutoantibodiesLabel freeRibonucleoproteinbusiness.industry010401 analytical chemistryAutoantibodyGeneral MedicineQuartz crystal microbalancePrognosis021001 nanoscience & nanotechnology0104 chemical sciencesInteraction fingerprintRibonucleoproteinsImmunologyQuartz Crystal Microbalance Techniques0210 nano-technologybusinessBiosensorBiotechnologyBiosensors and Bioelectronics
researchProduct

Collective agency and the concept of ‘public’ in public involvement: A practice-oriented analysis

2016

Background Public involvement activities are promoted as measures for ensuring good governance in challenging fields, such as biomedical research and innovation. Proponents of public involvement activities include individual researchers as well as non-governmental and governmental organizations. However, the concept of ‘public’ in public involvement deserves more attention by researchers because it is not purely theoretical: it has important practical functions in the guidance, evaluation and translation of public involvement activities. Discussion This article focuses on collective agency as one property a public as a small group of participants in a public involvement activity could exhib…

Biomedical ResearchHealth (social science)Debate0603 philosophy ethics and religionRepresentativeness heuristicHealth(social science)03 medical and health sciencesGood governance0302 clinical medicineHumansCollective agency030212 general & internal medicineSociologybusiness.industryHealth PolicyCommunity ParticipationRepresentation (systemics)06 humanities and the artsPublic relationsPublic involvementRepresentationCollective agencyPublic involvementIssues ethics and legal aspectsPhilosophy of medicine060302 philosophyProperty aElement (criminal law)businessBMC Medical Ethics
researchProduct

Anti-C1q Autoantibodies in Lupus Nephritis: Prevalence and Clinical Significance

2005

Recently, anti-C1q autoantibodies have been proposed as a useful marker in systemic lupus erythematosus (SLE) since their occurrence correlates with renal involvement and, possibly, with nephritic activity. We aimed to evaluate the prevalence of anti-C1q antibodies in patients with SLE, with and without renal involvement, and to correlate these markers' presence and levels with the activity of the disease and nephropathy. We studied 61 patients with SLE, 40 of whom had biopsy-proven lupus nephritis; 35 patients with other connective tissue diseases; and 54 healthy controls. In addition, 18 lupus nephritis patients were followed up during the disease time course. Anti-C1q antibodies were mea…

BiopsySLELupus nephritisEnzyme-Linked Immunosorbent AssaySystemic lupus erythematosuAnti-DNA antibodieSeverity of Illness IndexGeneral Biochemistry Genetics and Molecular BiologyFollow-Up StudieNephropathyCohort StudiesHistory and Philosophy of Scienceimmune system diseasesAutoimmune diseasePrevalencemedicineHumansLupus Erythematosus SystemicConnective Tissue DiseasesGlomerulonephritiskin and connective tissue diseasesRenal flareConnective Tissue DiseaseAutoantibodiesAutoimmune diseaseBiochemistry Genetics and Molecular Biology (all)Systemic lupus erythematosusbusiness.industryLupus nephritiComplement C1qGeneral NeuroscienceAutoantibodyGlomerulonephritisBiomarkermedicine.diseaseLupus NephritisAutoantibodieAntibodies Anti-IdiotypicItalyAntibodies AntinuclearImmunologyAnti-C1q antibodieCohort StudiebusinessNephritisBiomarkersFollow-Up StudiesHumanAnti-SSA/Ro autoantibodiesAnnals of the New York Academy of Sciences
researchProduct

Biosensor Analysis of β2-Glycoprotein I–Reactive Autoantibodies: Evidence for Isotype-Specific Binding and Differentiation of Pathogenic from Infecti…

2007

Abstract Background: For the laboratory diagnosis of the antiphospholipid syndrome (APS) we developed a biosensor with the ability to distinguish between disease-relevant anti-β2-glycoprotein I (β2GPI) autoantibodies (anti-β2GPI) and pathogen-specific β2GPI cross-reactive antibodies that occur transiently during infections. Methods: We used a surface plasmon resonance (SPR) biosensor device. For the detection of anti-β2GPI in serum samples, affinity-purified human β2GPI was covalently attached to a functionalized n-alkanethiol self-assembling monolayer on the biosensor chip. After verifying the specificity of the biosensor system with a panel of monoclonal antibodies to β2GPI, we analyzed s…

Biosensor devicemedicine.drug_classClinical BiochemistryEnzyme-Linked Immunosorbent AssayBiosensing TechniquesCross Reactionsmedicine.disease_causeMonoclonal antibodyAutoimmunityParvoviridae InfectionsAntiphospholipid syndromeParvovirus B19 HumanmedicineHumansLupus Erythematosus SystemicSyphilisTreponema pallidumAntigens ViralAutoantibodiesAntigens BacterialbiologyParvovirusBiochemistry (medical)AutoantibodySurface Plasmon ResonanceAntiphospholipid Syndromemedicine.diseasebiology.organism_classificationIsotypeMolecular biologyImmunoglobulin Isotypesbeta 2-Glycoprotein IImmunologyAntibodies Antiphospholipidbiology.proteinAntibodyProtein BindingClinical Chemistry
researchProduct

Neuroprotective effect of erythropoietin and darbepoetin alfa after experimental intracerebral hemorrhage.

2009

OBJECTIVE: Intracerebral hemorrhage (ICH) is a devastating clinical syndrome for which no truly efficacious therapy has yet been identified. In preclinical studies, erythropoietin (EPO) and its long-lasting analog, darbepoetin alfa, have been demonstrated to be neuroprotective in several models of neuronal insult. The objectives of this study were to analyze whether the systemic administration of recombinant human EPO (rHuEPO) and its long-lasting derivative darbepoetin alfa expedited functional recovery and brain damage in a rat model of ICH. METHODS: Experimental ICH was induced in rats by injecting autologous blood into the right striatum under stereotactic guidance. Subsequently, animal…

Brain InfarctionMaleDarbepoetin alfaBrain EdemaBrain damageNeuroprotectionDrug Administration ScheduleCentral nervous system diseaseRats Sprague-DawleyBlood Transfusion AutologousErythropoietin; Erythropoietin derivative; Intracerebral hemorrhage; Neuroprotectionhemic and lymphatic diseasesEdemamedicineAnimalsHumansDarbepoetin alfaErythropoietinCerebral HemorrhageIntracerebral hemorrhagebusiness.industryBasal Ganglia HemorrhageBrainmedicine.diseaseNeuroprotectionCorpus StriatumRecombinant ProteinsRatsErythropoietin derivativeDisease Models AnimalNeuroprotective AgentsTreatment OutcomeErythropoietinAnesthesiaErythropoietin Erythropoietin derivative Intracerebral hemorrhage NeuroprotectionSystemic administrationHematinicsSurgeryNeurology (clinical)medicine.symptomIntracerebral hemorrhagebusinessmedicine.drugNeurosurgery
researchProduct

Mildronate treatment improves functional recovery following middle cerebral artery occlusion in rats

2011

Mildronate (3-(2,2,2-trimethylhydrazinium) propionate) is an inhibitor of l-carnitine biosynthesis and an anti-ischemic drug. In the present study, we investigated the effects of mildronate in rats following focal cerebral ischemia. Male Wistar rats were subjected to transient occlusion of the middle cerebral artery (MCAO) for 90min, followed by the intraperitoneal administration of mildronate at doses of 100 and 200mg/kg 2h after reperfusion and then daily for an additional 14days. The beam-walking, rota-rod and cylinder tests were used to assess sensorimotor function, and vibrissae-evoked forelimb-placing and limb-placing tests examined responses to tactile and proprioceptive stimulation.…

Brain InfarctionMaleIschemiaStimulationPharmacologyRotarod performance testBrain ischemiaBehavioral NeuroscienceAdjuvants ImmunologicTandem Mass SpectrometryCarnitinemedicine.arterymedicineAnimalsRats WistarStrokeChromatography High Pressure LiquidAnalysis of VarianceDose-Response Relationship Drugbusiness.industryExtremitiesInfarction Middle Cerebral ArteryRecovery of Functionmedicine.diseaseRatsBetaineDose–response relationshipRotarod Performance TestVibrissaeMiddle cerebral arterySystemic administrationbusinessNeuroscienceLocomotionPsychomotor PerformanceMethylhydrazinesBehavioural Brain Research
researchProduct